Guerin P. Mark's most recent trade in Traws Pharma Inc. was a trade of 5,500 Restricted Stock Units done . Disclosure was reported to the exchange on June 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Traws Pharma Inc. | Mark P. Guerin | CFO | 10 Jun 2024 | 5,500 | 5,500 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | Mark P. Guerin | CFO | 10 Jun 2024 | 5,500 | 41,476 (0%) | 0% | - | Common Stock | ||
Traws Pharma Inc. | Mark P. Guerin | CFO | 10 Jun 2024 | 2,221 | 39,255 (0%) | 0% | 0.5 | 1,044 | Common Stock | |
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 13 Mar 2024 | 8,666 | 38,567 (0%) | 0% | - | Common Stock | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 13 Mar 2024 | 8,666 | 17,334 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 13 Mar 2024 | 2,591 | 35,976 (0%) | 0% | 0.9 | 2,332 | Common Stock | |
Traws Pharma Inc. | P. Mark Guerin | CFO AND COO | 07 Feb 2024 | 6,900 | 32,344 (0%) | 0% | - | Common Stock | ||
Traws Pharma Inc. | Guerin P. Mark | CFO AND COO | 07 Feb 2024 | 6,900 | 6,900 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | P. Mark Guerin | CFO AND COO | 07 Feb 2024 | 2,443 | 29,901 (0%) | 0% | 0.7 | 1,637 | Common Stock | |
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 02 Aug 2023 | 4,750 | 4,750 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 02 Aug 2023 | 4,750 | 26,866 (0%) | 0% | - | Common Stock | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 02 Aug 2023 | 1,422 | 25,444 (0%) | 0% | 1.0 | 1,450 | Common Stock | |
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 12 Jun 2023 | 5,500 | 23,691 (0%) | 0% | - | Common Stock | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 12 Jun 2023 | 5,500 | 11,000 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 12 Jun 2023 | 1,575 | 22,116 (0%) | 0% | 1.1 | 1,791 | Common Stock | |
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 13 Mar 2023 | 79,000 | 79,000 | - | - | Stock Option (right to purchase) | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 13 Mar 2023 | 26,000 | 26,000 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 07 Feb 2023 | 6,900 | 13,800 | - | - | Restricted Stock Units | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 07 Feb 2023 | 6,900 | 19,976 (0%) | 0% | - | Common Stock | ||
Traws Pharma Inc. | Mark P. Guerin | CFO AND COO | 07 Feb 2023 | 1,785 | 18,191 (0%) | 0% | 1.4 | 2,428 | Common Stock |